XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance at Dec. 31, 2022 $ 127 $ 50,618,137 $ (316,509) $ (44,958,199) $ 467,668 $ 5,811,224
Balance, shares at Dec. 31, 2022 126,673          
Issuance of common stock to noteholders $ 155 7,743,178 7,743,333
Issuance of common stock to noteholders, shares 154,867          
Exercise of warrants $ 73 14,527 14,600
Exercise of warrants, shares 73,324          
Share-based compensation expense $ 5 (5)
Share-based compensation expense, shares 4,650          
Issuance of warrants 47,876,820 47,876,820
Foreign currency translation 51,365 51,365
Net income (loss) (49,851,140) (49,851,140)
Balance at Mar. 31, 2023 $ 360 106,252,657 (316,509) (94,809,339) 519,033 11,646,202
Balance, shares at Mar. 31, 2023 359,514          
Balance at Dec. 31, 2022 $ 127 50,618,137 (316,509) (44,958,199) 467,668 5,811,224
Balance, shares at Dec. 31, 2022 126,673          
Net income (loss)           (62,157,538)
Forgiveness of interest – related parties          
Balance at Sep. 30, 2023 $ 844 109,782,103 (316,509) (107,115,737) 377,033 2,727,734
Balance, shares at Sep. 30, 2023 844,143          
Balance at Mar. 31, 2023 $ 360 106,252,657 (316,509) (94,809,339) 519,033 11,646,202
Balance, shares at Mar. 31, 2023 359,514          
Exercise of warrants $ 205 (4) 201
Exercise of warrants, shares 205,762          
Share-based compensation expense 189,000 189,000
Issuance of warrants 3,387,604 3,387,604
Foreign currency translation 86,267 86,267
Net income (loss) (8,853,248) (8,853,248)
Issuance of common stock - investors $ 19 (19)
Issuance of common stock - investors, shares 19,060          
Balance at Jun. 30, 2023 $ 584 109,829,238 (316,509) (103,662,587) 605,300 6,456,026
Balance, shares at Jun. 30, 2023 584,336          
Exercise of warrants $ 230 (230)
Exercise of warrants, shares 229,807          
Share-based compensation expense   (46,875) (46,875)
Foreign currency translation (228,267) (228,267)
Net income (loss) (3,453,150) (3,453,150)
Issuance of common stock to consultants $ 30 (30)
Issuance of common stock to consultants, shares 30,000          
Balance at Sep. 30, 2023 $ 844 109,782,103 (316,509) (107,115,737) 377,033 2,727,734
Balance, shares at Sep. 30, 2023 844,143          
Balance at Dec. 31, 2023 $ 942 108,620,942 (414,502) (113,278,588) 723,303 (4,347,903)
Balance, shares at Dec. 31, 2023 941,284          
Issuance of common stock to noteholders $ 295 1,207,705 1,208,000
Issuance of common stock to noteholders, shares 294,633          
Share-based compensation expense 33,938 33,938
Foreign currency translation (177,477) (177,477)
Net income (loss) (12) 1,940,975 1,940,963
Issuance of common stock - investors $ 173 709,827 710,000
Issuance of common stock - investors, shares 173,171          
Issuance of common stock to consultants $ 146 492,547 492,693
Issuance of common stock to consultants, shares 145,779          
Issuance of common stock to consultants $ 24 99,175 99,199
Issuance of common stock - conversions, shares 24,195          
Issuance of common stock – settlement of cash warrants $ 50 206,729 206,779
Issuance of common stock - settlement of cash warrants, shares 50,434          
Issuance of common stock to board of directors and former employees $ 78 262,838 262,916
Issuance of common stock to board of directors and former employees, shares 77,966          
Forgiveness of interest – related parties 3,006,896 3,006,896
Balance at Mar. 31, 2024 $ 1,708 114,640,597 (414,514) (111,337,613) 545,826 3,436,004
Balance, shares at Mar. 31, 2024 1,707,462          
Balance at Dec. 31, 2023 $ 942 108,620,942 (414,502) (113,278,588) 723,303 (4,347,903)
Balance, shares at Dec. 31, 2023 941,284          
Net income (loss)           3,212,482
Forgiveness of interest – related parties           3,006,896
Balance at Sep. 30, 2024 $ 2,377 122,415,733 (414,514) (110,066,094) 697,954 12,635,456
Balance, shares at Sep. 30, 2024 2,375,863          
Balance at Mar. 31, 2024 $ 1,708 114,640,597 (414,514) (111,337,613) 545,826 3,436,004
Balance, shares at Mar. 31, 2024 1,707,462          
Foreign currency translation (5,337) (5,337)
Net income (loss) 4,448,892 4,448,892
Issuance of common stock - investors $ 0 455 455
Issuance of common stock - investors, shares 200          
Issuance of common stock to consultants $ 10 39,990 40,000
Issuance of common stock - conversions, shares 10,000          
Issuance of common stock to board of directors and former employees $ 33 108,506 108,539
Issuance of common stock to board of directors and former employees, shares 32,835          
Forgiveness of interest – related parties 5,400,000 5,400,000
Balance at Jun. 30, 2024 $ 1,751 120,189,548 (414,514) (106,888,721) 540,489 13,428,553
Balance, shares at Jun. 30, 2024 1,750,497          
Share-based compensation expense 19,333 19,333
Foreign currency translation 157,465 157,465
Net income (loss) (3,177,373) (3,177,373)
Issuance of common stock - investors $ 626 2,206,852 2,207,478
Issuance of common stock - investors, shares 625,366          
Balance at Sep. 30, 2024 $ 2,377 $ 122,415,733 $ (414,514) $ (110,066,094) $ 697,954 $ 12,635,456
Balance, shares at Sep. 30, 2024 2,375,863